DAVEY B DANIEL
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology CHATTANOOGA, TN NPI 1942258751
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TN Acerta Pharma LLC All categories
General Payments — all program years on this page
$11,068.83
- Category: General Payments
- Program years: PY2018–2024
- Record count: 102
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $464.98 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $464.98 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $184.61 | 2 |
| Amgen Inc. | $178.44 | 2 |
| Regeneron Pharmaceuticals, Inc. | $43.35 | 1 |
| Lilly USA, LLC | $27.11 | 1 |
| PFIZER INC. | $17.11 | 1 |
| ABBVIE INC. | $14.36 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1103598678 | ABBVIE INC. | $14.36 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104449833 | AstraZeneca Pharmaceuticals LP | $127.21 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105790998 | AstraZeneca Pharmaceuticals LP | $57.40 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111558287 | Amgen Inc. | $25.00 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111558289 | Amgen Inc. | $153.44 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114397933 | Regeneron Pharmaceuticals, Inc. | $43.35 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131368981 | PFIZER INC. | $17.11 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136135203 | Lilly USA, LLC | $27.11 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.